Content about executive

ORLANDO, Fla. — Former Caremark Rx executive Drew Crawford has been appointed president and CEO of Benecard PBF, an administrator of prescription benefits and services to public and private plan sponsors.

Crawford is a former member of the executive management of Caremark Rx and is the son of Mac Crawford, who served as chairman, president and CEO of Caremark Rx and also is the former chairman of CVS Caremark.

WOONSOCKET, R.I. — CVS Caremark has named Helena Foulkes, who is widely regarded as one of the most visionary marketers in modern drug store retailing, to the newly created position of EVP and chief healthcare strategy and marketing officer.

In the new role, Foulkes will bring together the company's capabilities in enterprise branding, communications, community relations, charitable giving, healthcare-reform strategy, government relations and marketing into one integrated organization in an effort to deliver even better business results and stronger partnerships.

NEW YORK — Following the recent sale of Walgreens' pharmacy benefit management business, Credit Suisse analysts said they are interested in the executive team's updated thinking on their healthcare strategy and plans for the $550 million in proceeds.

ARLINGTON, Va. — The Healthcare Distribution Management Association on Tuesday honored Neil Warren of Cardinal Health with its Distribution Management Award for Career Achievement.

The award, presented at the HDMA’s 2011 Distribution Management Conference and Technology Expo in Tampa, Fla., recognizes a distribution industry professional with at least 15 years of service who demonstrates the highest standards of integrity, has made significant contributions to the healthcare distribution industry and is respected by peers and trading partners.

WASHINGTON — The American Pharmacists Association is looking for a new CFO to replace Roger Browning, who will retire, the group said Tuesday.

Browning has worked in senior financial executive positions for the APhA since 1995, serving as SVP finance and CFO since 2007. Before working for the APhA, he was VP finance at the International Franchise Association.

ORLANDO, Fla. — The Generic Pharmaceutical Association has elected its 2011 executive committee and board of directors, the generic drug industry trade group announced. As part of a reorganization last year, the board has been reduced to 12 members.

The GPhA said Watson Pharmaceuticals president and CEO Paul Bisaro had been reelected as chairman for a second, one-year term. Also elected were Mylan Pharmaceuticals president Tony Mauro, as vice chairman; and Momenta Pharmaceuticals president Craig Wheeler, as secretary treasurer.

In November 2010, The Drug Store News Group/Specialty Pharmacy magazine hosted in New York an exclusive executive round-table discussion of leading specialty pharmacy providers. Guest moderator David Galardi of Apogenics and the panel examine why more therapeutic classes are migrating to a specialty-preferred model, working with Medicaid, genetic testing and REMS. Click below to download a PDF of the round-table transcript.

SUPPLIER NEWS — Pacific World is launching exclusively at Walmart in March its new GeoGirl eco-friendly beauty line for tweens. The 69-SKU collection, which has suggested retail pricing between $3.98 and $5.98, includes makeup for face, lips, cheeks and eyes, as well as skin and body care. The formulas are made with 100%-natural fragrances, and the packaging is made of recyc­lable materials.



COVENTRY, England — A U.K.-based community pharmacy chain has appointed Tony Page as its managing director, effective next week.

Lloydspharmacy, which operates 1,650 community pharmacies across the United Kingdom, said Page is a seasoned retail executive with more than 23 years of experience.

INDIANAPOLIS — Following the exit of its oncology unit leader, drug maker Eli Lilly announced two executive changes.

Sue Mahony, currently SVP human resources and diversity, has been named SVP and president of Lilly Oncology, effective immediately. Mahony will remain a member of Lilly's executive committee. She succeeds John Johnson, who resigned from his post at Lilly last month to become CEO of Savient Pharmaceuticals.

LONDON — Public policies to support medical innovation will help drug companies address diseases that devastate people’s lives, a drug company executive said at a summit Thursday.

Speaking at The Economist magazine’s 2011 Pharma Summit, Eli Lilly chairman, president and CEO John Lechleiter called for a new approach to research in such illnesses as Alzheimer’s disease, diabetes and cancer. This included changing the way companies conduct research and public policies that promote an environment in which innovation can flourish.